PatternsRadar
Sign in

BAFNAPHBafna Pharmaceuticals Limited

NSEESM 1Band 5%
469.95INR-9.55 (-1.99%)Close · 20 Nov 2026
11 Nov 2026Last results
—Sector
—Industry
₹1,112 CrMarket cap
96.6P/E (TTM)
100.0%Delivery

Filings & corporate actions

27 results filed
CSV
Next results · Q3 FY27
Expected 7 Feb 2027 – 13 Feb 2027
Estimate: filed 38–44 days after quarter end, last 5 times
2026
  • 11 NovresultsResults · Q2 FY27 · standalone+2.0%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026-2.0%NSE
  • 11 AugresultsResults · Q1 FY27 · standalone-2.0%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+1.4%NSE
  • 29 MayresultsResults · Q4 FY26 · standalone+5.0%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+2.2%NSE
  • 11 FebresultsResults · Q3 FY26 · standalone-3.5%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-4.3%NSE

Reaction to results · all yearsrose on day 0 in 17 of 27 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2711 Nov 2026+2.0%-0.6%—0.2×
Q1 FY2711 Aug 2026-2.0%-11.4%+10.2%0.1×
Q4 FY2629 May 2026+5.0%+47.1%+62.7%3.6×
Q3 FY2611 Feb 2026-3.5%-9.6%-22.7%1.3×
Q2 FY2611 Nov 2025-2.0%-11.4%-27.3%6.9×
Q1 FY2612 Aug 2025+10.0%+10.0%+29.5%15.3×
Q4 FY2526 May 2025+2.2%0.0%+3.7%1.0×
Q3 FY257 Feb 2025+1.2%-6.3%+2.0%0.9×
Q2 FY2512 Nov 2024-1.8%-3.2%-1.8%1.4×
Q1 FY2514 Aug 2024+2.7%-3.8%-7.3%1.5×
Q4 FY2430 May 2024-5.0%-7.5%-4.4%0.1×
Q3 FY2413 Feb 2024+0.5%-3.5%-12.4%0.5×
Q2 FY2410 Nov 2023+3.0%+6.3%+23.2%0.2×
Q1 FY2412 Aug 2023+5.0%+9.7%-4.9%0.3×
Q4 FY2327 May 2023+5.0%+33.8%-3.0%0.8×
Q3 FY239 Feb 2023-2.2%-4.4%-3.3%2.0×
Q2 FY2312 Nov 2022+2.0%-1.5%+1.3%0.8×
Q1 FY2312 Aug 2022+5.0%+6.5%+1.9%12.3×
Q4 FY2227 May 2022+3.3%+1.3%-0.7%0.3×
Q3 FY2211 Feb 2022-2.6%-14.5%-23.4%0.9×
Q2 FY2212 Nov 2021+5.0%-2.6%+7.3%3.2×
Q1 FY225 Aug 2021-2.2%-4.2%-14.7%0.3×
Q4 FY2126 Jun 2021+1.0%-2.5%+10.6%2.1×
Q3 FY2112 Feb 2021+5.0%+9.7%+32.0%0.8×
Q2 FY2112 Nov 2020+5.0%-8.1%+12.9%0.6×
Q1 FY2110 Sept 20200.0%+27.0%+161.3%0.1×
Q4 FY2025 Jun 20200.0%0.0%+61.4%0.3×
Average+1.5%+2.1%+11.3%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY20

Revenue YoY+34.4%
Profit YoY+119.1%
Interest cost YoY+19.2%
Revenue QoQ+79.3%
Profit QoQ+9018.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+3.9%-0.9%+20.1%+11.7%——
Profit+431.9%-12.5%+33.2%+7.5%——

Key data

Open485.00
Day range469.95 – 489.00
52-week range94.77 – 501.65
From 52w high-6.3%
RSI (14)58.7
ATR (14)10.87
Volume6.6K
Avg volume (20D)11.3K
Rel volume0.59×
Volatility (1Y)48.9%
Turnover₹32.1L
Traded value (NSE)₹32.1L
VWAP482.68
SMA 50 / 200411.47 / 232.68
Price band5%

Delivery percentage

Latest · 20 Nov 2026100.0%
20-day avg100.0%
1-year avg95.5%
Percentile (own history)100th
Range0.9–100.0%
Sessions1,493

Over the last 20 sessions BAFNAPH settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 95.5%, so recent sessions are running 4.5 points higher than usual. That is the highest reading in the 1,493 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders6.8K · -3.6% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy106 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.99%-2.51%+3.98%+97.71%+245.96%+159.40%

Valuation

Market cap₹1,112 Cr
Market cap (NSE)₹1,112 Cr
Free-float cap₹278 Cr
P/E (TTM)96.6
P/E (NSE)95.0
EPS (TTM)4.87
P/B10.8
Net margin (TTM)7.4%
Other income / PBT53.0%
ROE11.8%
Debt / equity0.36
Shares outstanding23.65L
Listed—

Ownership

Promoter75.00%
Promoter Δ QoQ0.00 pp
Public25.00%
FII9.34%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

Q4 FY20
Revenue (₹ Cr)13.1
YoY chg—
Net profit (₹ Cr)0.3
YoY chg—
Net margin2.4%
EPS0.20

Shareholding over time

By quarter

30 Sept 2026 · promoter 75.00% · public 25.00%
30 Sept 2021: promoter 90.40%31 Dec 2021: promoter 90.42%31 Mar 2022: promoter 90.42%30 Jun 2022: promoter 90.12%30 Sept 2022: promoter 90.00%31 Dec 2022: promoter 90.02%31 Mar 2023: promoter 90.00%30 Jun 2023: promoter 90.00%30 Sept 2023: promoter 88.74%31 Dec 2023: promoter 88.43%31 Mar 2024: promoter 88.30%30 Jun 2024: promoter 88.30%30 Sept 2024: promoter 88.30%31 Dec 2024: promoter 88.30%31 Mar 2025: promoter 75.00%30 Jun 2025: promoter 75.00%30 Sept 2025: promoter 75.00%31 Dec 2025: promoter 75.00%31 Mar 2026: promoter 75.00%30 Jun 2026: promoter 75.00%30 Sept 2026: promoter 75.00%
2021-092026-09
  • Promoter
  • Public and others
Promoter
75.00%
Public
25.00%
Promoter change
0.00 pp
Filed
21 Oct 2026
FII
9.34%
DII
0.00%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
9.34%

0.00 pp QoQ

Retail ≤ ₹2L
5.48%

+0.50 pp QoQ

HNI > ₹2L
6.49%

-0.50 pp QoQ

NRI
0.53%

-0.01 pp QoQ

Bodies corporate
2.48%

-0.03 pp QoQ

Shareholders
6,810

-3.6% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
SRJR LIFESCIENCES LLPPromoter · Corporate74.57%
CULLINAN OPPORTUNITIES FUND VCC-CULLINAN OPPORTUNITIES INCORPORATED VCC SUB FUND 1FPI3.21%
M7 GLOBAL FUND PCC-CELL DEWCAP FUNDFPI3.12%
ZEAL GLOBAL OPPORTUNITIES FUNDFPI3.01%
ALPANA MUNDRAIndividual2.73%
MONARCH NETWORTH FINSERVE PRIVATE LIMITEDCorporate1.35%
GUTTIKONDA VARA LAKSHMIIndividual1.29%
P PARAS BAFNAPromoter · Individual0.21%
NAVIN BAFNAPromoter · Individual0.18%
MAHAVEER CHAND BAFNAPromoter · Individual0.03%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
15
6 open-market of the newest 15
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
22 Sept 2022SRJR LIFESCIENCES LLPPromoterSell8.9K₹9.2L103.022.12Cr → 2.12Cr89.57%-0.04 pp7(2)told 20 Sept 2022
17 Sept 2022SRJR LIFESCIENCES LLPPromoterSell9.9K₹10.8L109.672.12Cr → 2.12Cr89.60%-0.04 pp7(2)told 15 Sept 2022
17 Jun 2022SRJR LIFESCIENCES LLPPromoterSell27.2K₹33.5L123.032.13Cr → 2.12Cr89.72%-0.12 pp7(2)told 16 Jun 2022
9 Jun 2022SRJR LIFESCIENCES LLPPromoterSell13.1K₹16.7L127.002.13Cr → 2.13Cr89.84%-0.06 pp7(2)told 8 Jun 2022
6 Jun 2022SRJR LIFESCIENCES LLPPromoterSell11.1K₹13.7L123.002.13Cr → 2.13Cr89.89%-0.05 pp7(2)told 6 Jun 2022
6 Jun 2022SRJR LIFESCIENCES LLPPromoterSell14.8K₹17.5L118.622.13Cr → 2.13Cr89.93%-0.06 pp7(2)told 3 Jun 2022

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 6 Aug 2026

CSV
2 of 2 deals
By year
DateDealClientQuantityPriceValue
6 Aug 2026Buy · bulkCULLINAN OPPRTS FUND VCC-CULLINAN OPPORTUNITIES INCORPORATED VCC SUB FUND 16.66L284.55₹19.0Cr
6 Aug 2026Sell · bulkM7 GLOBAL FUND PCC-AERION6.66L284.55₹19.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Exchange surveillance

20 Nov 2026
  • ESM · stage 1 · since 20 Nov 2026 — Enhanced Surveillance Measure, for companies under ₹500 crore: a 5% or 2% price band and trade-for-trade settlement.
  • P/E > 50 (4 quarters) · since 16 Nov 2026 — P/E above 50 on the last four quarters’ earnings.
  • Under 100 traders in 30 days · since 13 Jul 2026 — Fewer than 100 distinct investors traded it in the last 30 days.

Price band: 5% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q4 FY20A
Revenue from operations13.1
Other income(0.7)
Total income12.5
Total expenses9.4
└ Finance costs0.0
└ Depreciation0.5
Profit before tax2.2
Tax expense1.6
Net profit0.3
EPS0.20
Net margin2.42%
PBT margin16.62%
Tax rate72.30%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 25 Jun 2020.

1 quarter on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets129.6134.9147.7134.2153.1160.7175.5193.0
Current assets87.390.994.574.684.780.189.7101.8
└ Cash & equivalents7.87.91.41.33.40.32.01.3
└ Other bank balances0.00.00.00.00.00.00.00.0
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables41.139.845.433.740.232.643.950.0
└ Inventories22.229.429.627.528.131.028.932.2
Total equity73.582.480.882.884.891.296.1103.2
└ Attributable to owners73.582.480.882.884.891.296.1103.2
└ Share capital23.723.723.723.723.723.723.723.7
Borrowings22.916.624.418.828.232.437.437.2
└ Current14.59.513.67.514.213.119.723.0
└ Non-current8.47.110.811.314.019.317.814.2
Trade payables28.530.235.422.930.926.031.341.6
Current liabilities46.544.254.138.051.947.857.271.3
Total liabilities56.152.566.851.468.369.579.489.8
Net debt15.18.723.017.524.832.135.435.9
Debt / equity0.310.200.300.230.330.360.390.36
Current ratio1.882.061.751.961.631.671.571.43

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow5.011.29.516.022.19.315.410.1
└ Capex(8.2)(3.9)(15.8)(9.3)(21.9)(16.4)(24.9)(8.9)
Free cash flow(3.3)7.3(6.4)6.70.3(7.1)(9.5)1.1
Investing cash flow(7.5)(3.8)(15.1)(9.2)(21.2)(14.9)(22.4)(8.9)
Financing cash flow10.2(7.3)(0.8)(6.9)1.12.45.6(1.9)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash7.60.0(6.4)(0.1)2.0(3.2)(1.4)(0.7)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

BAFNAPH at a glance

  • BAFNAPH closed at ₹469.95 on 20 Nov 2026, -1.99% on the day, +159.4% over one year, 6.3% below its 52-week high of ₹501.65.
  • Delivery was 100.0% of traded quantity on 20 Nov 2026, the 100th percentile of its own 1,493 sessions with a reading (20-session average 100.0%, 1-year average 95.5%).
  • Market capitalisation is ₹1,112 crore at a trailing P/E of 96.6 (trailing EPS ₹4.87).
  • Q4 FY20 results (consolidated, filed 25 Jun 2020): revenue ₹13 crore, net profit ₹0 crore; the price moved 0.0% on the first session after.
  • Promoters held 75.00% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 7 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sector—
Basic industry—
ISININE878I01022
SeriesBE
Listed—
NSE market cap · 17 Nov 2026—
Free-float market cap (NSE)—
Shares outstanding (NSE)—
History from2 Mar 2020
Sessions1,499

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.